Ocuphire Pharma | Investor Presentation Deck

Slide schematic 5/5

list 1/1 other 2/2 paragraph 1/1 title 1/1

Components 5

bullet unclassified unclassified paragraph headline

Tools 1

list/bullet: Successful EOP2 FDA meeting completed in October 2023; agreement that a 3-step change on the binocular person scale is an approvable registration endpoint

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

Ocuphire Pharma | Investor Presentation Deck | 42 slides · slide 30